Instructions for Authors

Instructions for Authors

Archives of the Turkish Society of Cardiology is a peer-reviewed journal published by the Turkish Society of Cardiology. The journal publishes researches, medical news, regulations, and abstracts submitted in national congresses of cardiology. The journal accepts manuscripts written in Turkish, and in English.

Archives of the Turkish Society of Cardiology accepts various types of articles which will be briefly described below.

Research Articles

Archives of the Turkish Society of Cardiology accepts original clinical (conducted with healthy subjects or patients) or experimental (human, animal or in-vitro trials) research articles performed in all fields of cardiovascular diseases.

Review Articles

Reviews are usually invited by the Editors. Archives of the Turkish Society of Cardiology publishes both clinical and basic science review articles on all aspects of cardiovascular medicine.

How to Section

These educational, and instructive articles relate to the specific practical methods of performing cardiovascular procedures.

Editorial Comments

This section contains Editors’ comments and reviews about cardiovascular, and other relevant issues.

Case Reports

Archives of the Turkish Society of Cardiology publishes reports on interesting, instructive or rarely seen cases.

Case Images

Archives of the Turkish Society of Cardiology also publishes educative or rarely seen radiological images, (electrocardiograms, echocardiograms, plain radiograms, angiograms, CTs, and MRIs, macroscopic or microscopic slides of histopathologic specimens). It also encourages submission of cases in video format, and displays these videos online.

Letters to the Editor

This section contains comments, criticisms and contributions about a published paper in the Archives of Turkish Society of Cardiology. Author(s) of the criticized article has the right to reply. In this section the commented article should be mentioned in the References section. Letters must be sent to the Editor, within 4 weeks following publication of the commented article in the Journal.

Expert Opinion

These concise articles reflect the opinion of an expert on a particular subject.

General Format

All manuscripts should be written on A4 white papers, and 2.5 cm-wide margins should be left blank from all sides of the manuscript. The references should be numbered consecutively in the order of their first mention in the text. All text material including references, footnotes, and legends of tables, and figures should be typed double-spacing in font size 11 with left alignment, and without hyphenated line breaks. To set left indent for the paragraph click TAB button once. Fonts of Times New Roman or Arial should be used in the text, for symbols, and other special writing characteristics. Please use editing features of your word processing program to type bold, italic letters, mathematic symbols, and Greek letters, subscripts, and superscripts. Please take care not to confuse between letters O, and I with numerals 0, and 1, respectively. As measurement units only SI (International System of Units) system should be used. Abbreviations and acronyms should be written in parentheses following their explicit open forms or explanations given in their first appearance in the text. Please review the final version of the manuscript very carefully, especially for formatting, and editing errors.

All pages of the manuscript should be consecutively numbered starting from the title page (1. page, title page; 2. page, Turkish abstract; 3. page English abstract etc.) Page numbers should be indicated on the right upper corner of each page.

Final version of the manuscripts should be typed in “doc” or “rtf” format. Manuscripts submitted in “PDF” format will not be accepted.

Writing rules of the Journal are based on the document entitled Uniform Requirements for Manuscripts Submitted to Biomedical Journals - International Committee of Medical Journal Editors (

Maximum word length, number of authors, references, and table/figures should be based on the following table.

Word* Reference Table/Figure Author
Research Article 6000 50 10 All
Review 6000 50 8
Case Report 2500 15 5 5
Editorial 2000 10 5 1
Letter to editor 500 5 2 2
How to section 1500 0 5 2
Case image 250 0 5 5
Expert opinion 250 0 0 1
*including title page, abstract, figure legend, and table
†for meta-analyses and systematic reviews all authors

Sections of the Manuscript

All research articles must contain the following sections: (1) Title page, (2) Abstract with key words, (3) Introduction, (4) Methods, (5) Results, (6) Discussion , (7) Acknowledgments, (8) Conflict of interest, (9) Funding resources, (10) References, (11) Figure legends, (12) Tables, (13) Figures. In case of need, presentation of Methods, Results, and Discussion sections under subheadings is preferred. Case reports should be presented following abstract section, under headings of introduction, case presentation, and discussion. In review articles, appropriate headings can be used in accordance with the development of the manuscript. Sections of the manuscript in order of their appearance in the text with relevant explanations are listed below.

Title Page

Title page should contain the following information. (1) Article title, (2) Explicit names, and academic titles of all participating authors, (3) The department(s), and institution(s) of all authors including their city, and country of residence, (4) The name, explicit mailing address, phone and fax numbers, e-mail address of the corresponding author, (5) Word counts (including title page, abstract, figures legends, and tables).

If the study was presented elsewhere, it should be indicated separately on the title page.


Following title page, abstract should be written on separate page. Abstracts should individually contain at most 250 words, and structured as follows: (1) Objective, (2) Methods, (3) Results, and (4) Conclusion. Under the above headings briefly, subject of the article, method of the study, basic findings, and conclusion arrived by the authors based on these findings should be provided. In the abstracts of the case report, any subtitle should not be used. In abstracts minimal number of abbreviations and/or acronyms should be used. Abstracts should not contain any reference. At most five key words should be written at the bottom of the abstract page.For the selection of keywords, please refer to the “Medical Subject Headings (MeSH)” prepared by US National Library of Medicine (NLM).


Available data relevant to the study subject, and specific purpose of the study should be stated.


The study method, selection of the participants, and the methods used should be described in detail. For the known methods references should be cited. Novel or modified methods used should be described in detail. Doses, concentrations, routes, and duration of administration of the drugs, and chemical agents should be indicated. In the Methods section, under a subtitle, all statistical methods used for summarizing available data, and for testing the proposed hypothesis, and a p value criteria determined for statistically significant difference should be briefly, and concisely recorded. All manuscripts accepted for publication should be statistically evaluated in detail. Standard statistical methods should be used as far as possible. If rarely employed and novel statistical methods were used, then relevant references should be cited. In case of need, more detailed explanations about unusual, complex or new statistical methods can be provided in separate files for the readers as online supplementary data. Commercial name and version number of the statistical software package program should be mentioned. For statistical evaluations recommendations in the statistics section of the document entitled “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication,” ( should be taken into consideration.


Results should be presented in logical sequence, and in detail as much as possible. They should be supported by figures, and tables. Information given in figure(s), and table(s) should not be repeated in the text, unless absolutely required.


Mainly data relevant to the study subject matter should be discussed, and substantiated by references retrieved from domestic and international sources. General information irrelevant to the subject matter should not be dealt with in prolonged discussions.


Names of the individuals who contributed to the study but failed to meet the criteria of authorship should be mentioned in this section. Approvals of all the individuals mentioned in the Acknowledgment section should be obtained.

Conflict of Interest

All potential conflicts of interest should be declared under this heading. All affiliations with pharmaceutical firms, biomedical device manufacturers, and other service or product procurers relevant to the subject matter of the study should be explicitly indicated. If any conflict of interest does not exist, then it should be stated as “none declared.” Declarations related to conflicts of interest should be placed at the bottom of a separate page after Acknowledgments, but before References section. A Conflict of Interest Form will be sent to the authors of accepted papers.

Funding sources

Under this heading titles and /or names of the funds, sponsor foundations or institutions (if any) should be written.


References should be listed consecutively in the order of their first appearance in the text, unpublished results and personal communications should not be cited as references. Unconfirmed references during the preparation stage for publication of the manuscript will be requested from the authors. Titles of the Journals should be abbreviated as indicated in Index Medicus. If not possible, then the full name of the journal should be written. In the References section, only 6 authors should be cited with their full surnames, and then initials of their first names. If more than six authors contributed to the article, then after the name of the 6 first six authors the abbreviation et al. should be added. Notation and listing of the references should comply with the following sample reference citations:

1) Journal

Yüksel H, Güzelsoy D, Yazıcıoğlu N, Şenocak M, Öztürk M, Demiroğlu C. Long-term prognosis after a first myocardial infarction in Turkey: determinants of mortality and reinfarction. Cardiology 1994;84:345-55.

2) Articles in press

Roten L, Derval N, Sacher F, Pascale P, Wilton SB, Scherr D, et al. Ajmaline attenuates electrocardio- gram characteristics of inferolateral early repolarization. Heart Rhythm 2011 Sep 19 [E-pub ahead of print], doi:10.1016/j.hrthm.2011.09.013.

3) Book

Katz AM. Physiology of the heart. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

4) Chapter in book

Anderson JL, Muhlestein JB. The role of infection. In: Theroux P, editor. Acute coronary syndromes: a companion to Braunwald’s Heart Disease. Philadelphia: W. B. Saunders; 2003. p. 88-107.

5) Web page

Nainggolan L. New salt paper causes controversy. Heartwire. May 3, 2011. Available at: Accessed June 12, 2011.

Reference management softwares (EndNote, Reference Manager, etc.) can be used to facilitate referencing citations. EndNote style for Archives of the Turkish Society of Cardiology can be downloaded from here.

Figure Legends

Explanatory notes of each figure should be submitted on a separate paper in order of their appearance in the text immediately after the References section under the heading “figure legends”. All abbreviations, and symbols on the figure should be defined.


Each table should be typed or printed with double-spacing on a separate sheet of paper. Tables should be numbered consecutively in the order of their first citation in the text. Number and title of the table should be placed just above the table. Do not use vertical lines between columns. Horizontal lines should be used only above, and below the headings of the columns, and at the bottom of the table. If required, explanatory notes should be written in footnotes. All abbreviations, and acronyms used in the table should be explained as in footnote in alphabetical order The following symbols should be used in the indicated sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡, §§, ||||, ¶¶. Each table should be referred in the text. If you use data from another published or unpublished source, required permissions should be obtained, and all these sources should be acknowledged fully.


Evaluation process of a manuscript does not start unless all figures cited in the text are submitted. Number of figures should be in accordance with the content of the text. Data presented in the text, and tables should not be repeated in figures. All figures should be sent in individual electronic file formats ready for publication with maximal dimensions of 12.5 cm x 18 cm. Illustrations in color should be in CMYK format and at a minimum resolution of 300 DPI. Figure depicted in gray scale should be at least at a resolution of 600 DPI, while minimal resolution required for black-and white illustrations is 1200 DPI. All figures should be typed in TIFF format. Any figure should not disclose or imply the identity of a specific individual. In case of disclosure of personal identity, written permission should be obtained from the individual in question.

Supplementary material, which might be beneficial for the reader but not required for the publication of a manuscript can be submitted online. Thus, method, and results of the study can be presented with more detail, and the manuscript can be substantiated with additional figure(s)/table(s) or moving pictures. All supplementary data must be referred to at an appropriate point in the text.

Authors are encouraged to submit video clips (AVI, MPEG or MOV formats).To facilitate downloading and online viewing, please take care that each file size does not exceed 10 Mb. Videos of longer procedures can be sent as multiple brief videos. A brief legend explaining the contents of the video should be provided. A discrete file should be sent for explanatory notes of the videos, and for each video a separate page should be reserved.

Pharmaceutical trials should be conducted in compliance with the relevant regulations of the Ministry of Health and Social Welfare, and also approval of the institutional ethics committee should be obtained. These prerequisite criteria should be met, and indicated during submission process of the manuscript. Failure to comply with these requirements will lead to rejection of the manuscript for publication. Besides, criteria of Helsinki Declaration, Guidelines for Good Clinical Practices and also Guidelines for Good Laboratory Practices should be adhered to in all medical trials, informed written and verbal approvals of the patients should be obtained.
All individuals listed as “author” in the submitted manuscript must make adequate contribution to the study, meet the criteria of authorship, and take responsibility for his own part in the manuscript. For the sake of outcomes, and integrity of the study, at least one author should be responsible for each section of the manuscript. The ICMJE recommends that authorship be based on the following 4 criteria:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

2. Drafting the work or revising it critically for important intellectual content; AND

3. Final approval of the version to be published; AND

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In multi-centered studies, all individuals who are named as authors under the title of the article should meet all the above-mentioned requirements of the authorship. Searching, and providing financial support for the study and/or data collection do not satisfy the criteria of authorship per se. Besides general support or guidance provided for the study investigators is not a prerequisite for authorship. Individuals who contributed to the study in various ways, but fail to meet the criteria of authorship can be included in the “Acknowledgements” section after their written and undersigned permission. Please refer toICMJE  website for more information about authorship. Increasing the number of authors unnecessarily is not an ethical code of conduct, which provides unfair academic prestige, and various advantages for those concerned. In this case, to prevent implementation of this unethical code of conduct, the editor may request from the authors declaration of their own contributions to the article, and publish this information if deemed appropriate. Sequence of authors should be based on the consensus reached by all authors. Due to differences in specification of the sequence of authors, the reported sorting will be taken as a basis unless otherwise stated. Authors can explain the rationale for a different sorting in a footnote.

Each manuscript should be sent with a cover letter, which must contain the following items that explicitly declare that:

1) All authors are meeting the criteria of authorship.

2) The submitted manuscript was not simultaneously sent to another journal or it is not presently being evaluated by another journal.

3) No part of the content of the manuscript has been previously published elsewhere.

4) The manuscript has been read, and approved by all authors.

The name, explicit address, phone, and fax number(s), and e-mail address of the corresponding author to whom all editorial correspondences will be directed should be indicated in this section. A brief paragraph emphasizing the scientific significance of the manuscript can be included in this section.

All manuscripts should be submitted to Archives of the Turkish Society of Cardiology via online submission system. For questions or requests related to submission, and evaluation process of the manuscripts the editorial office can be contacted at In compliance with journal’s publication rules, the current state of the manuscript will not be discussed on phone. After preparation of the manuscript in accordance with the above-indicated requirements, go to the online submission system page. The first-time users should complete their registration. Then a user name, and a code specific to user will be sent to his/her e-mail address. For further details, please consult to online manuscript submission page.There is no fee for article submission, article processing or publication.
For the publication of the article in the journal, it should not be published elsewhere, and deemed to be suitable for publication by the decree of the Editorial Board selected by Executive Committee of the Turkish Society of Cardiology. The whole responsibility of the manuscript belongs to the author(s). Evaluation process of the submitted manuscript starts after receival of a document containing undersigned approvals obtained from all authors. During typesetting, and preparatory procedures of the manuscripts appropriate for publication a Copyright Transfer Form will be sent to the primary author(s) (“guarantors”) who will assume the whole responsibility of the manuscript.

All submitted manuscripts are initially evaluated by the editorial board. At this stage manuscripts not deemed to be suitable for publication in Archives of the Turkish Society of Cardiology, including those not complying with writing rules, and requirements or without adequate scientific content will be returned to the authors. Manuscripts found suitable for publication will be sent to reviewers for more detailed evaluation. Acceptability of manuscripts is dependent on originality, scientific content, and subject of the study in accordance with the publication protocol of the journal. All research articles deemed suitable for publication are subjected to a detailed statistical evaluation. Authors are informed of the editor’s decision about the acceptability of the manuscript via e-mail usually within 6 weeks of its submission. The editors do not discuss their decision on phone. All objections and wishes should be communicated to the editors in a written format. If deemed necessary, Editorial Board has the right to make modifications in the text without altering main concept of the manuscript. An offprint of the manuscript will not be sent to the author(s).

The manuscripts are scanned by the Publisher's Office using the iThenticate program for determination of plagiarism and non-ethical situations.

All published material will become the sole property and will be copyrighted by the Journal. No part of the publication may be used without prior written permission of the publisher. Articles and illustrations become the property of the Journal after publication.

Open Access
The TKDA is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

Commons User Licenses
Creative Commons Attribution-NonCommercial (CC BY-NC) For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work, as long as they credit the author(s) and provided they do not alter or modify the article.

Editorial Office
Archives of the Turkish Society of Cardiology
Nish Istanbul
A Blok Kat: 8, No: 47-48
Çobançeşme, Sanayi Cad. No: 11
34196 Istanbul, Turkey.
Tel:  +90 (212) 221 1730
Fax: +90 (212) 221 1754
© copyright 2017 Archives of the Turkish Society of Cardiology
LookUs & Online Makale